Table 1 Expression of miR-145-5p is elevated in chronic inactive lesion tissue from SPMS and RRMS patients

From: Loss of miR-145 promotes remyelination and functional recovery in a model of chronic central demyelination

Disease

Sex

Age (yrs)

Disease duration (yrs)

EDSSa

Tissue type

miR-145-5p expression ± SEM

FCb/mean HCc

SPMSd

M

61

26

9.5

NAWMf

0.67 ± 0.01

1.58

Chronic Inactive

1.27 ± 0.03

3.00

Active

0.39 ± 0.04

0.93

SPMS

M

65

13-15

9

NAWM

0.45 ± 0.01

1.06

Chronic Inactive

3.64 ± 0.20

8.59

Chronic Inactive

3.29 ± 0.12

7.77

Active

0.20 ± 0.01

0.48

SPMS

F

60

28

8.5

NAWM

0.53 ± 0.01

1.25

Chronic Inactive

1.36 ± 0.08

3.21

Active

0.41 ± 0.02

0.96

SPMS

M

48

6

8.5

NAWM

0.63 ± 0.03

1.48

Chronic Inactive

1.84 ± 0.05

4.36

Active

0.27 ± 0.01

0.63

RRMSe

M

26

12

9

NAWM

0.43 ± 0.01

1.03

Chronic Inactive

2.28 ± 0.03

5.40

Active

0.33 ± 0.02

0.79

HC

M

64

--

--

WMg

0.17 ± 0.00

--

HC

M

67

--

--

WM

0.46 ± 0.02

--

HC

F

37

--

--

WM

0.68 ± 0.02

--

HC

M

42

--

--

WM

0.38 ± 0.01

--

  1. aExpanded Disability Status Scale.
  2. bFold Change.
  3. cHealthy Control.
  4. dSecondary Progressive Multiple Sclerosis.
  5. eRelapsing-Remitting Multiple Sclerosis.
  6. fNormal Appearing White Matter.
  7. gWhite Matter.